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Abstract 
A novel series of thiepine derivatives were synthesized and evaluated as potential antimicrobials. All 
the synthesized compounds were evaluated for their antimicrobial activities in vitro against the fungi 
Candida albicans (ATCC 10231), C. parapsilosis (clinical isolate), Gram-negative bacterium 
Pseudomonas aeruginosa (ATCC 44752), and Gram-positive bacterium Staphylococcus aureus (ATCC 
25923). Synthesized compounds showed higher antifungal activity than antibacterial activity 
indicating that they could be used as selective antimicrobials. Selected thiepines efficiently inhibited 
Candida hyphe formation, a trait necessary for their pathogenicity. Thiepine 8-
phenyl[1]benzothiepino[3,2-c]pyridine (16) efficiently killed Candida albicans at 15.6 µg/mL and 
showed no embryotoxicity at 75 µg/mL. Derivative 8-[4-(4,5-dihydro-1H-imidazol-2-
yl)phenyl][1]benzothiepino[3,2-c]pyridine (23) caused significant hemolysis and in vitro DNA 
interaction. The position of the phenyl ring was essential for the antifungal activity, while the 
electronic effects of the substituents did not significantly influence activity. Results obtained from in-
vivo embryotoxicity on zebrafish (Danio rerio) encourage further structure optimizations. 
 
Introduction 
Notable biological activities have been described for the members of the dibenzo[b,f]thiepine 
series (1). Zotepine 1 (Figure 1) is a thiepine antipsychotic drug that has been used in clinical 
practice for the treatment of schizophrenia for several decades (2). The results published 
recently have shown that dibenzo[b,f]thiepines and pyridobenzothiepines exhibit anticancer 
(3) and antifungal activity (4). These results strongly support that thiepines are an important 
class of biologically active heterocyclic molecules. 
Having transitioned from a rare incidence to an everyday problem, invasive fungal infections are a 
rapidly increasing global threat to human health. In the developed world, fungal infections 
predominantly occur in the context of increasingly aggressive immunosuppressive therapies. 
Invasive candidiasis is the fourth most common bloodstream infection (surpassing many bacterial 
pathogens) in the United States and the statistics are similar for Europe (5). Candida species now 
account up to 9% of all bloodstream infections with mortality rates remaining disturbingly high at 
40%, despite the advent of new diagnostic and therapeutic strategies (6).  More than 17 different 
Candida species are known to be etiological agents of human infection, however, more than 90% of 
invasive infections are caused by C. albicans, C. glabrata, C. parapsilosis and C. krusei (7). The 
expanding population of immune-compromised patients that use intravenous catheters, total 
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parenteral nutrition, invasive procedures and the growing use of broad-spectrum antibiotics, are 
factors that contribute to the increase of Candida infections and consequently to the increased need 
of new therapeutic options.  
 
 
Figure 1. Structure of zotepine. 
 
Different approaches have been used for the synthesis of the thiepine derivatives,(1,8,9,10,11) 
including the two that involve palladium-catalyzed reactions as a ring-closing step. Nielsen and the 
coworkers published the protocol with the Mizoroki-Heck cyclisation of the corresponding diaryl 
(thio)ethers as a final step (12). In our previous work we described the ring closure using the double 
palladium-catalyzed S-arylation of the ortho-halogen-substituted Z-stilbenes (13). The described 
methodology for the C-S bond formation and the previously synthesized thiepines 2-5 are shown in 
Scheme 1. 
 
 
Scheme 1. Reagents and conditions: (i) Pd(OAc)2, dppf, KSAc, NaOt-Bu, PhMe, 175 °C, μW. 
In the preliminary disc-diffusion assay have shown that initial benzothiepino[3,2-c]pyridines had 
weak antibacterial activity and better antifungal activity (4). Encouraged by these results, we 
synthesized a series of novel benzothiepino[3,2-c]pyridine derivatives, and for all new thiepines, and 
previously synthesized derivatives we evaluated their antimicrobial potential in detail, as well as 
toxicity in vertebrate model organism (Danio rerio). All tested compounds have exhibited higher 
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antifungal than antibacterial activity. Some of the synthesized compounds efficiently inhibited the 
growth of C. parapsilosis that showed resistance to common antifungal drugs. In-vivo embryotoxicity 
on zebrafish (Danio rerio) showed improved toxicity profile of the three most active derivatives in 
comparison to that of voriconazole. 
 
Experimental Section 
Melting points were determined on a Boetius PMHK apparatus and were not corrected. IR spectra 
were recorded on a Thermo-Scientific Nicolet 6700 FT-IR Diamond Crystal.  NMR: 1H and 13C NMR 
spectra were recorded on a Bruker Ultrashield Advance III spectrometer (at 500 and 125 MHz, 
respectively) using tetramethylsilane (TMS) as the internal standard. The NMR solvents are specified 
individually for each compound. Chemical shifts are expressed in parts per million (ppm) on the (δ) 
scale. Chemical shifts were calibrated relative to those of the solvents. ESI MS spectra of the 
synthesized compounds were recorded on an Agilent Technologies 6210 Time-of-Flight LC/MS 
instrument in positive ion mode using CH3OH/H2O = 1:1 with 0.2 % HCOOH as the carrying solvent 
solution. The samples were dissolved in pure methanol (HPLC grade).  The selected values were as 
follows: capillary voltage = 4 kV; gas temperature = 350 °C; drying gas = 12.l min-1; nebulizer pressure 
= 45 psig; fragmentator voltage = 70 V. All yields reported refer to isolated yields. Compounds were 
analyzed for purity using: Agilent 1200 HPLC system equipped with Quat Pump (G1311B), Injector 
(G1329B) 1260 ALS, TCC 1260 ( G1316A) and Detector 1260 DAD VL+ (G1315C), and Waters 1525 
HPLC dual pump system equipped with an Alltech Select degasser system, and a dual λ 2487 UV-VIS 
detector. 
The synthesis of compounds 2, 3, 4, 5, and 16 were previously described (4,13). 
 
10,11-dibromo-10,11-dihydro[1]benzothiepino[3,2-c]pyridine (6) 
A solution of Br2 in carbon tetrachloride (0.2 mL, 1.1 eq, 0.1 M) was added to the solution of alkene 3 
(4.2 mg, 0.020 mmol) in carbon tetrachloride (0.1 mL). After stirring at room temperature for 16 
hours, the reaction mixture was washed with saturated aqueous Na2S2O3 and water, dried over 
MgSO4 and concentrated in vacuum. Crystallization from ethanol yielded pale red crystals (7.3 mg, 
100%), mp 138-140 °C. 1H NMR (500 MHz, CDCl3) δ 8.45 (s, 1H), 8,34 (d, J = 5.0 Hz, 1H), 7.44 (dd, J = 
7.8 Hz, J = 1.8 Hz, 1H), 7.38-7.26 (m, 3H), 7.23 (d, J = 5.5 Hz, 1H), 5.79 (d, J = 7.0 Hz, 1H), 5.71 (d, J = 
7.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 153.0, 148.2, 145.4, 136.6, 132.8, 132.6, 131.4, 129.8, 
129.3, 127.4, 122.0, 52.7, 50.8. IR (ATR, cm-1): 3405w, 3169w, 3043m, 2958s, 2928s, 2852m, 2585m, 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
2361m, 1714w, 1626s, 1574m, 1513w, 1458m, 1263s, 1099m, 1021m, 805m, 765w, 735s, 699w, 
619w. (+)ESI-HRMS (m/z): [M + H]+ 369.88848 (error: -2.81 ppm). 
 
11-bromo[1]benzothiepino[3,2-c]pyridine (7) and 10-bromo[1]benzothiepino[3,2-c]pyridine (8) 
In an oven-dried flask, vicinal dibromide 6 (61.0 mg, 0.164 mmol) was disolved in tert-butyl alcohol 
(2.2 mL) and potassium tert-butoxide (22.1 mg, 0.197 mmol, 1.2 equiv.) was added. After heating 
under reflux for 2 h, reaction mixture was poured onto ice and concentrated in vacuum. Water and 
diethyl ether were added, and the ether phase was separated and washed with saturated aqueous 
Na2S2O3 solution. The organic extract was dried over Na2SO4, concentrated in vacuum and purified 
by preparative column chromatography (SiO2, hexane/EtOAc = 9:1) to afford the compound 7 (37.7 
mg, 78%) as the colorless oil and compound 8 (5.7 mg, 12%) as the colorless oil.  
7: 1H NMR (500 MHz, CDCl3) δ 8.97 (s, 1H), 8.49 (d, J = 5.0 Hz, 1H), 7.82 (s, 1H), 7.51-7.46 (m, 1H), 
7.38-7.35 (m, 1H), 7.35-7.30 (m, 2H), 7.28-7.24 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 152.2, 150.5, 
146.1, 138.7, 138.3, 136.0, 133.4, 133.0, 129.8, 129.2, 128.9, 126.2, 122.8. IR (ATR, cm-1): 3362m, 
3048m, 2924s, 2852m, 1729w, 1604w, 1561s, 1535m, 1467s, 1432w, 1396m ,1271m, 1166w, 
1055w, 910w, 830w, 768w, 749m. (+)ESI-HRMS (m/z): [M + H]+ 289.96339 (error: 0.11 ppm). The 
compound was > 95% pure based on HPLC purity analysis. 
8: 1H NMR (500 MHz, CDCl3) δ 8.53-8.43 (m, 2H), 7.85-7.77 (m, 1H), 7.70 (s, 1H), 7.50-7.45 (m, 1H), 
7.42-7.31 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 149.6, 149.4, 145.4, 140.2, 134.6, 134.2, 133.2, 131.4, 
131.0, 129.0, 128.6, 126.3. IR (ATR, cm-1): 3359m, 3056m, 3026s, 2924s, 2852m, 1732w, 1612w, 
1565s, 1539m, 1492w, 1469s, 1444m, 1396m, 1367w, 1260w, 1239w, 1177w, 1056w, 948w, 924w, 
828w, 772s, 750m, 739m, 702s. (+)ESI-HRMS (m/z): [M + H]+ 289.96228 (error: -3.71 ppm). 
 
General procedure for the Suzuki reactions (with 11-bromo[1]benzothiepino[3,2-c]pyridine or 10-
bromo[1]benzothiepino[3,2-c]pyridine): 
The reaction tube containing a stirring bar was evacuated and backfilled with Ar. The tube was 
charged with Pd(OAc)2 (3 mol %), triphenylphosphine (12 mol %) and 1,2-dimethoxyethane. After 
stirring at room temperature for 10 min, appropriate vinyl bromide and sodium carbonate (aq, 2 M) 
were added and stirring was continued for 10 min. A solution of boronic acid (1.25 equiv.) in ethanol 
was added, the tube was capped and the reaction mixture was heated to 90 °C and stirred at the 
same temperature overnight. The products were purified by preparative column chromatography: 
SiO2, hexane/EtOAc = 8:2. 
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11-phenyl[1]benzothiepino[3,2-c]pyridine (9) 
Following general procedure, a mixture of Pd(OAc)2 (0.2 mg, 3 mol%), triphenylphosphine (0.9 mg, 
12 mol %), Na2CO3 (aq) (2 M, 20 μL), 11-bromo[1]benzothiepino[3,2-c]pyridine (8.0 mg, 0.028 
mmol), phenylboronic acid (4.2 mg, 0.034 mmol), ethanol (100 μL) and 1,2-dimethoxyethane (150 
μL) was stirred at 90 °C for 15 hours. White solid (3.9 mg, 50%), mp 134-135 °C. 1H NMR (500 MHz, 
CDCl3) δ 8.47 (d, J = 5.0 Hz, 1H), 8.21 (s, 1H), 7.53-7.50 (m, 1H), 7.49-7.47 (m, 1H), 7.46-7.44 (m, 1H), 
7.42-7.28 (m, 8H). 13C NMR (125 MHz, CDCl3) δ 151.6, 149.5, 146.6, 143.4, 143.0, 139.8, 137.5, 134.1, 
133.7, 132.6, 129.6, 129.1, 128.8, 128.6, 128.5, 128.2, 126.7. IR (ATR, cm-1): 3055s, 3028s, 2924m, 
2852w, 1608w, 1563s, 1538m, 1493m, 1469s, 1445m, 1394m, 1369w, 1272m, 1068w, 1032w, 833m, 
762s, 700m. (+)ESI-HRMS (m/z): [M + H]+ 288.08333 (error: -2.58 ppm). The compound was > 95% 
pure based on HPLC purity analysis. 
 
11-(4-methoxyphenyl)[1]benzothiepino[3,2-c]pyridine (10) 
Following general procedure, a mixture of Pd(OAc)2 (0.3 mg, 3 mol%), triphenylphosphine (1.3 mg, 
12 mol %) Na2CO3 (aq) (2 M, 30 μL), 11-bromo[1]benzothiepino[3,2-c]pyridine (12.0 mg, 0.041 
mmol), 4-methoxyphenylboronic acid (7.8 mg, 0.052 mmol) and 1,2-dimethoxyethane (220 μL) was 
stirred at 90 °C for 15 hours. White solid (11.9 mg, 92%), mp 153-155 °C. 1H NMR (500 MHz, CDCl3) δ 
8.46 (d, J = 5.0 Hz, 1H), 8.23 (s, 1H), 7.52-7.46 (m, 2H), 7.42-7.26 (m, 6H), 6.97-6.89 (m, 2H), 3.85 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 159.7, 151.7, 149.4, 146.5, 142.9, 140.0, 137.6, 135.5, 134.1, 132.6, 
132.5, 130.0, 129.4, 128.9, 128.5, 126.7, 114.0, 55.4. IR (ATR, cm-1): 3278w, 3033m, 3003m, 2954m, 
2926s, 2851m, 1734w, 1605m, 1565m, 1511s, 1468m, 1394w, 1370w, 1294m, 1252s, 1181m, 
1034m, 832m, 752m. (+)ESI-HRMS (m/z): [M + H]+ 318.09501 (error: 0.95 ppm). The compound was 
> 95% pure based on HPLC purity analysis. 
 
11-(4-fluorophenyl)[1]benzothiepino[3,2-c]pyridine (11) 
Following general procedure, a mixture of Pd(OAc)2 (0.5 mg, 3 mol%), triphenylphosphine (2.2 mg, 
12 mol %), Na2CO3 (aq) (2 M, 60 μL), 11-bromo[1]benzothiepino[3,2-c]pyridine (20.0 mg, 0.069 
mmol), 4-fluorophenylboronic acid (12.0 mg, 0.086 mmol), ethanol (300 μL) and 1,2-
dimethoxyethane (450 μL) was stirred at 90 °C for 15 hours. White solid (12.6 mg, 60%), mp 131-133 
°C. 1H NMR (500 MHz, CDCl3) δ 8.48 (d, J = 5.0 Hz, 1H), 8.19 (s, 1H), 7.54-7.47 (m, 2H), 7.43-7.28 (m, 
6H), 7.14-7.05 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 162.8 (d, J = 246.5 Hz), 151.5, 149.6, 146.6, 
142.3, 139.6, 139.1, 137.3, 134.1, 133.7, 132.7, 130.5 (d, J = 8.0 Hz), 129.5, 129.2, 128.6, 126.8, 115.6 
(d, J = 20.8 Hz). IR (ATR, cm-1): 3301w, 3223w, 3048w, 2923s, 2852m, 1734m, 1600w, 1564w, 1539w, 
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1507m, 1468m, 1394w, 1268m, 1232m, 1160w, 834m, 740m. [M + H]+ 306.07480 (error: 0.23 ppm). 
The compound was > 95% pure based on HPLC purity analysis. 
 
4-[1]benzothiepino[3,2-c]pyridin-11-ylbenzonitrile (12) 
Following general procedure, a mixture of Pd(OAc)2 (0.9 mg, 3 mol%), triphenylphosphine (4.4 mg, 
12 mol %), Na2CO3 (aq) (2 M, 120 μL), 11-bromo[1]benzothiepino[3,2-c]pyridine (40.0 mg, 0.138 
mmol), 4-cyanophenylboronic acid (25.3 mg, 0.172 mmol), ethanol (600 μL) and 1,2-
dimethoxyethane (1.0 mL) was stirred at 90 °C for 15 hours. Pale yellow oil (24.9 mg, 58%). 1H NMR 
(500 MHz, CDCl3) δ 8.51 (d, J = 5.0 Hz, 1H), 8.13 (s, 1H), 7.74-7.68 (m, 2H), 7.56-7.50 (m, 4H), 7.50-
7.47 (m, 1H), 7.42-7.32 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 151.0, 150.0, 147.3, 147.2, 141.6, 139.0, 
136.6, 135.6, 134.2, 132.8, 132.5, 129.8, 129.8, 129.4, 128.7, 127.0, 118.5, 111.9. IR (ATR, cm-1): 
3056m, 2926m, 2679w, 2227s, 1606s, 1566m, 1540w, 1508m, 1470m, 1433w, 1396m, 1274m, 
1171w, 1062w, 836s, 772w, 749m, 701w. [M + H]+ 313.07878 (error: -1.96 ppm). The compound was 
> 95% pure based on HPLC purity analysis. 
 
11-pyridin-4-yl[1]benzothiepino[3,2-c]pyridine (13) 
Following general procedure, a mixture of Pd(OAc)2 (0.5 mg, 3 mol%), triphenylphosphine (2.2 mg, 
12 mol %), Na2CO3 (aq) (2 M, 50 μL), 11-bromo[1]benzothiepino[3,2-c]pyridine (20.0 mg, 0.069 
mmol), 4-pyridinylboronic acid (10.6 mg, 0.086 mmol), ethanol (250 μL) and 1,2-dimethoxyethane 
(700 μL) was stirred at 90 °C for 15 hours. White film (10.6 mg, 53%). 1H NMR (500 MHz, CDCl3) δ 
8.70-8.65 (m, 2H), 8.52 (d, J = 5.0 Hz, 1H), 8.17 (s, 1H), 7.56-7.52 (m, 2H), 7.51 (d, J = 5.0 Hz, 1H), 
7.42-7.31 (m, 5H). 13C NMR (125 MHz, CDCl3) δ 151.0, 150.3, 150.1, 150.0, 147.3, 140.8, 139.0, 136.2, 
135.6, 134.3, 132.9, 129.9, 129.8, 128.7, 127.0, 123.2. IR (KBr, cm-1): 3426s, 3028w, 2922s, 2852m, 
1730w, 1632w, 1593m, 1564w, 1541w, 1469m, 1400w, 1276w,1100m, 821w, 754w, 615w, 549m. 
(+)ESI-HRMS (m/z): [M + H]+ 289.07948 (error: 0.29 ppm). 
 
10-phenyl[1]benzothiepino[3,2-c]pyridine (14) 
Following general procedure, a mixture of Pd(OAc)2 (0.5 mg, 3 mol%), triphenylphosphine (2.2 mg, 
12 mol %), Na2CO3 (aq) (2 M, 50 μL), 10-bromo[1]benzothiepino[3,2-c]pyridine (20.0 mg, 0.069 
mmol), phenylboronic acid (10.5 mg, 0.086 mmol), ethanol (250 μL) and 1,2-dimethoxyethane (700 
μL) was stirred at 90 °C for 15 hours. White solid (12.7 mg, 64%), mp 134 °C. 1H NMR (500 MHz, 
CDCl3) δ 8.59 (s, 1H), 8.44 (d, J = 5.5 Hz, 1H), 7.61-7.55 (m, 1H), 7.47-7.36 (m, 6H), 7.35-7.28 (m, 2H), 
7.23-7.17 (m, 1H), 7.05-7.00 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 150.0, 149.0, 148.6, 145.9, 143.6, 
141.7, 135.7, 135.0, 133.3, 131.2, 129.8, 128.9, 128.4, 128.4, 128.3, 128.1, 126.0. IR (ATR, cm-1): 
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3054w, 3021w, 2919w, 2851w, 1562w, 1539w, 1464m, 1390w, 1236w, 1174w, 916w, 864w, 825m, 
748m, 691m, 636w, 551w, 518w. (+)ESI-HRMS (m/z): [M + H]+ 288.08472 (error: 1.98 ppm). The 
compound was > 95% pure based on HPLC purity analysis. 
 
10-(4-methoxyphenyl)[1]benzothiepino[3,2-c]pyridine (15) 
Following general procedure, a mixture of Pd(OAc)2 (0.5 mg, 3 mol%), triphenylphosphine (2.2 mg, 
12 mol %), Na2CO3 (aq) (2 M, 50 μL), 10-bromo[1]benzothiepino[3,2-c]pyridine (20.0 mg, 0.069 
mmol), 4-methoxyphenylboronic acid (13.1 mg, 0.086 mmol), ethanol (250 μL) and 1,2-
dimethoxyethane (700 μL) was stirred at 90 °C for 15 hours. White solid (20.3 mg, 93%), mp  145-146 
°C. 1H NMR (500 MHz, CDCl3) δ 8.58 (s, 1H), 8.43 (d, J = 5.5 Hz, 1H), 7.60-7.54 (m, 1H), 7.41-7.35 (m, 
3H), 7.35-7.30 (m, 1H), 7.26 (s, 1H), 7.24-7.19 (m, 1H), 7.07-7.04 (m, 1H), 6.95-6.91 (m, 2H), 3.86 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 159.7, 150.0, 148.8, 148.1, 145.8, 141.9, 136.1, 135.9, 135.0, 133.3, 
131.3, 130.0, 129.8, 128.3, 127.2, 126.0, 113.8, 55.4. IR (ATR, cm-1): 3031m, 2954m, 2930m, 2835w, 
1605m, 1566m, 1537w, 1511s, 1467m, 1394w, 1365w, 1295m, 1249s, 1180m, 1113w, 1034m, 
833m, 776w, 750w. (+)ESI-HRMS (m/z): [M + H]+ 318.09449 (error: -0.70 ppm). The compound was > 
95% pure based on HPLC purity analysis. 
 
General procedure for Suzuki reactions (with 8-chloro[1]benzothiepino[3,2-c]pyridine): 
The reaction tube containing a stirring bar was evacuated and backfilled with Ar. The tube was 
charged with Pd(OAc)2 (5 mol %), SPhos (10 mol %), boronic acid (1.2 equiv.) and anhydrous K3PO4 
(2.0 equiv.). The tube was capped with a rubber septum and filled with argon. Dry toluene was 
added through the septum and the resulting mixture was stirred at room temperature for 2 min. 8-
Chloro[1]benzothiepino[3,2-c]pyridine was added and the tube was sealed. The reaction mixture 
was heated at 100 °C overnight. The reaction mixture was allowed to cool to room temperature. The 
products were purified by preparative column chromatography (SiO2, hexane/EtOAc = 8/2). 
 
8-(4-methoxyphenyl)[1]benzothiepino[3,2-c]pyridine (17) 
Following general procedure, a mixture of Pd(OAc)2 (0.3 mg, 1 mol%), SPhos (1.0 mg, 10 mol %), 
anhydrous K3PO4 (51.8 mg, 0.224 mmol), 8-chloro[1]benzothiepino[3,2-c]pyridine (30.0 mg, 0.122 
mmol), 4-methoxyphenylboronic acid (22.3 mg, 0.146 mmol) and toluene (1.5 mL) was heated at 
100 °C overnight. White solid (24.0 mg, 62%), mp 133-134 °C. 1H NMR (500 MHz, CDCl3) δ 8.50-8.42 
(m, 2H), 7.52-7.44 (m, 4H), 7.42-7.38 (m, 1H), 7.36-7.33 (m, 1H), 7.16 (d, J = 12.5 Hz, 1H), 7.02-6.93 
(m, 3H), 3.83 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 159.5, 149.9, 149.8, 144.7, 141.5, 139.9, 136.1, 
135.4, 133.8, 132.7, 130.8, 130.5, 128.0, 128.0, 127.9, 126.2, 114.3, 55.3. IR (ATR, cm-1): 3023m, 
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2959w, 2842w, 1607m, 1567m, 1543w, 1510s, 1467s, 1390w, 1301m, 1265m, 1242s, 1171w, 1025w, 
835m, 806m. (+)ESI-HRMS (m/z): [M + H]+ 318.09491 (error: 0.63 ppm). The compound was > 95% 
pure based on HPLC purity analysis. 
 
4-[1]benzothiepino[3,2-c]pyridin-8-ylbenzonitrile (18) 
Following general procedure, a mixture of Pd(OAc)2 (0.3 mg, 1 mol%), SPhos (1.0 mg, 10 mol %), 
anhydrous K3PO4 (51.8 mg, 0.224 mmol), 8-chloro[1]benzothiepino[3,2-c]pyridine (30.0 mg, 0.122 
mmol), 4-cyanophenylboronic acid (21.4 mg, 0.146 mmol) and toluene (2 mL) was heated at 100 °C 
overnight. Yellow oil (14.0 mg, 36%). 1H NMR (500 MHz, CDCl3) δ 8.52-8.45 (m, 2H), 7.76-7.70 (m, 
2H), 7.68-7.61(m, 2H), 7.59-7.50 (m, 2H), 7.47-7.44 (m, 1H), 7.37 (d, J = 5.0 Hz, 1H), 7.18 (d, J = 12.0 
Hz, 1H), 7.06 (d, J = 12.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 150.1, 150.0, 144.4, 144.1, 140.3, 
139.8, 135.6, 135.2, 133.7, 133.4, 132.7, 131.3, 128.4, 127.6, 126.3, 118.6, 111.6. IR (ATR, cm-1): 
3311w, 2954m, 2921m, 2851m, 2226w, 1771w, 1735m, 1651m, 1561m, 1540m, 1519m, 1465m, 
1373w, 1266w, 1178w, 824w, 737w. (+)ESI-HRMS (m/z): [M + H]+ 313.07895 (error: -1.42 ppm). The 
compound was > 95% pure based on HPLC purity analysis. 
  
General procedure for C-S coupling: 
11-(phenylthio)[1]benzothiepino[3,2-c]pyridine (19) 
The reaction tube containing a stirring bar was evacuated and backfilled with Ar. The tube was 
charged with Pd2dba3 (5.5 mg, 5 mol %), dppf (6.7 mg, 10 mol %), sodium tert-butoxide (13.9 mg, 
0.145 mmol, 1.2 equiv.) and toluene (2.5 mL). The tube was evacuated and backfilled with argon. 
After stirring at room temperature for 10 min, 11-bromo[1]benzothiepino[3,2-c]pyridine (7) (35.0 
mg, 0.121 mmol) and thiophenol (13 μL, 0.133 mmol, 1.1 equiv.) were added. The tube was capped 
and the reaction mixture was heated to 90 °C and stirred at the same temperature overnight. The 
product was purified by preparative column chromatography: SiO2, hexane/EtOAc = 9:1. Yellow solid 
(30.0 mg, 77%), mp 108-110 °C. 1H NMR (500 MHz, CDCl3) δ 9.03 (s, 1H), 8.36 (d, J = 5.0 Hz, 1H), 7.67 
(s, 1H), 7.52-7.47 (m, 1H), 7.43-7.37 (m, 2H), 7.35-7.32 (m, 1H), 7.32-7.28 (m, 2H), 7.25-7.19 (m, 3H), 
7.16-7.11 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 151.0, 150.1, 146.7, 139.0, 138.7, 136.9, 135.1, 134.1, 
134.0, 132.7, 130.1, 129.5, 129.2, 129.0, 128.7, 127.1, 126.4. IR (ATR, cm-1): 3056w, 3023w, 1712w, 
1562w, 1466w, 1388w, 1266w, 1184w, 1081w, 1026w, 948w, 883w, 832w, 742m, 697w, 619w. 
(+)ESI-HRMS (m/z): [M + H]+ 320.05694 (error: 2.24 ppm). The compound was > 95% pure based on 
HPLC purity analysis. 
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4-([1]benzothiepino[3,2-c]pyridin-11-ylthio)benzonitrile (20) 
Following general procedure, a mixture of Pd2dba3 (11.0 mg, 5 mol %), dppf (11.9 mg, 10 mol %), 
sodium tert-butoxide (28.6 mg, 0.289 mmol, 1.2 eq), 11-bromo[1]benzothiepino[3,2-c]pyridine (70.0 
mg, 0.241 mmol), 4-mercaptobenzonitrile (50.0 μL, 0.366 mmol, 1.5 equiv.) and toluene (5.0 mL) 
was stirred at 90 °C overnight.  The product was purified by preparative column chromatography: 
SiO2, hexane/EtOAc = 8:2. Yellow solid (55.6 mg, 67%), mp 158-160 °C. 1H NMR (500 MHz, CDCl3) δ 
8.99 (s, 1H), 8.41 (d, J = 5.0 Hz, 1H), 7.92 (s, 1H), 7.56-7.52 (m, 1H), 7.46-7.33 (m, 7H), 7.32-7.29 (m, 
1H). 13C NMR (125 MHz, CDCl3) δ 150.6, 150.5, 146.7, 143.4, 142.2, 138.5, 134.9, 134.2, 133.2, 132.9, 
132.4, 130.3, 129.2, 128.9, 127.9, 126.5, 118.4, 109.5. IR (ATR, cm-1): 3072w, 3041w, 2936w, 2320w, 
1589m, 1558s, 1464m, 1428w, 1396m, 1269w, 1188w, 1082w, 951w, 825s, 753m. (+)ESI-HRMS 
(m/z): [M + H]+ 345.04998 (error: -4.30 ppm). The compound was > 95% pure based on HPLC purity 
analysis. 
 
General procedure for the synthesis 4,5-dihydro-1H-imidazole derivatives 
11-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl][1]benzothiepino[3,2-c]pyridine (21) 
A mixture of sulfur (1.2 mg, 0.038 mmol) and 12 (12.0 mg, 0.038 mmol) was treated with ethylene 
diamine (0.5 mL), then irradiated with microwave at 110 °C for 80 min. The mixture was suspended 
in water, the phases were separated using centrifugation and the precipitate was rinsed with water 
(3×). The residue was then dried under vacuum, affording the product as a yellow film (12.0 mg, 
88%). 1H NMR (500 MHz, d-DMSO, CF3COOD) δ 8.77 (d, J = 6.0 Hz, 1H), 8.38 (s, 1H), 8.16 (d, J = 6.0 
Hz, 1H), 8.00 (d, J = 8.5 Hz, 2H), 7.91 (s, 1H), 7.72 (d, J = 8.5 Hz, 2H), 7.61-7.56 (m, 1H), 7.55-7.50 (m, 
1H), 7.44-7.38 (m, 2H), 3.98 (s, 4H). 13C NMR (125 MHz, d-DMSO) δ 163.3, 150.7, 150.0, 146.1, 144.1, 
141.7, 139.3, 136.6, 134.2, 133.4, 132.5, 130.4, 130.2, 129.7, 129.0, 128.4, 127.5, 126.9, 54.9. IR 
(ATR, cm-1): 3302w, 3197m, 3025m, 2929m, 2874m, 1670w, 1605m, 1562m, 1514m, 1468m, 1395w, 
1347w, 1272m, 979w, 844m, 758w. (+)ESI-HRMS (m/z): [M + H]+ 356.12178 (error: 0.51 ppm). The 
compound was > 95% pure based on HPLC purity analysis. 
 
11-{[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]thio}[1]benzothiepino[3,2-c]pyridine (22) 
Following general procedure, a mixture of sulfur (2.0 mg, 0.064 mmol), 20 (22.0 mg, 0.064 mmol) 
and ethylene diamine (0.8 mL) was irradiated with microwave at 110 °C for 80 min. Yellow solid 
(21.1 mg, 85%), mp 156-158 °C. 1H NMR (500 MHz, d-DMSO, CF3COOD) δ 9.00 (s, 1H), 8.53 (d, J = 5.0 
Hz, 1H), 8.19 (s, 1H), 7.78 (d, J = 8.5 Hz, 2H), 7.71 (d, J = 5.0 Hz, 1H), 7.61-7.58 (m, 1H), 7.58-7.45 (m, 
5H), 3.94 (s, 4H). 13C NMR (125 MHz, d-DMSO, CF3COOD) δ 164.5, 149.2, 148.6, 148.3, 144.7, 143.3, 
143.3, 138.3, 135.7, 133.1, 131.8, 131.2, 130.2, 129.6, 129.4, 127.8, 127.6, 120.0, 44.5, 44.4. IR (ATR, 
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cm-1): 3439w, 3323w, 3247m, 3138m, 3062m, 2917m, 2869m, 1704w, 1605m, 1557m, 1466m, 
1392w, 1351w, 1272m, 1180w, 1122w, 1092w, 831m, 756m. (+)ESI-HRMS (m/z): [M + H]+ 388.09197 
(error: -4.38 ppm). 
 
8-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl][1]benzothiepino[3,2-c]pyridine (23) 
Following general procedure, a mixture of sulfur (0.8 mg, 0.025 mmol), 18 (8.5 mg, 0.025 mmol) and 
ethylene diamine (0.5 mL) was irradiated with microwave at 110 °C for 80 min. Yellow film (7.0 mg, 
80%). 1H NMR (500 MHz, d-DMSO, CF3COOD) δ 8.91 (s, 1H), 8.80 (d, J = 6.0 Hz, 1H), 8.06-7.97 (m, 
5H), 7.95-7.90 (m, 2H), 7.62 (d, J = 8.0 Hz, 1H), 7.49 (d, J = 12.5 Hz, 1H), 7.23 (d, J = 12.5 Hz, 1H), 4.02 
(s, 4H). 13C NMR (125 MHz, d-DMSO, CF3COOD) δ 164.7, 152.5, 144.2, 143.8, 143.0, 139.8, 139.7, 
138.2, 137.5, 134.0, 131.1, 129.6, 129.3, 129.2, 128.8, 127.6, 121.7, 121.6, 44.6, 44.4. IR (KBr, cm-1): 
3429m, 2924w, 1618m, 1565w, 1518w, 1466w, 1388w, 1275w, 1243w, 1196w, 1021w, 827w, 669w, 
617w. (+)ESI-HRMS (m/z): [M + H]+ 356.12141 (error: -0.52 ppm). 
 
Antimicrobial activity assay and microscopy 
Test organisms for the antibacterial assays were obtained from the National Collection of Type 
Cultures (NCTC) and the American Type Culture Collection (ATCC). They included Candida albicans 
(ATCC 10231) and C. parapsilosis C27 (voriconazole resistant clinical isolate; from the collection of 
National Reference Medical Mycology Laboratory (Institute of Microbiology and Immunology, 
Faculty of Medicine, University of Belgrade, Belgrade))), Gram negative strain Pseudomonas 
aeruginosa PAO1 (NCTC 10332) and Gram positive Staphylococcus aureus (NCTC 6571). Broth 
microdilution assays were carried out in RPMI medium (Sigma Aldrich, Germany) according to the 
standards recommended by the National Committee for Clinical Laboratory Standards (M07-A8) for 
bacteria and Standards of European Committee on Antimicrobial Susceptibility Testing (EDef7.1.) 
(14). Tested compounds were dissolved in DMSO. The highest concentration used was 500 μg/mL. 
The inoculums were 105 colony forming units (cfu) per mL for bacteria, and 104 cfu/mL for Candida 
sp.. 
 
To study the effect of selected thiepines on C. albicans cells in time, overnight fungal culture grown 
in RPMI medium (Sigma Aldrich, Germany) supplemented with 2 % glucose and 10 % FCS (fetal calf 
serum) was diluted to optical density OD600 of 0.5 and the thiepines or DMSO were added in MIC 
concentrations.  Culture was further incubated at 37 °C, and the aliquots were analysed by 
microscopy after 1, 5 and 24 h incubation.  Culture aliquots were stained with FUN 1 yeast cell stain 
([2-chloro-4-(2,3-dihydro-3-methyl-(benzo-1,3-thiazol-2-yl)-methylidene)-1-phenylquinolinium 
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iodide]) used under the manufacturer’s instructions (Molecular Probes, Inc.), and observed using 
fluorescence microscope (Olympus BX51, Applied Imaging Corp., San Jose, USA) at 40× 
magnification. 
 
Hemolysis assay (15) 
Sheep red blood cells in PBS, pH 7.4 (1% v/v, Torlak, Belgrade, Serbia) were treated for 1 h 
with concentration of compounds that corresponded to determined MIC and IC50 values at 
37°C.  Hemoglobin absorbance was measured at 405 nm (Tekan Infinite 200 Pro multiplate 
reader; Tecan Group Ltd., Männedorf, Switzerland).  The hemolysis percentage was 
calculated using the following equation: hemolysis (%) = 100[(Abs405nm (treated) - Abs405nm 
(non treated) / (Abs405nm (0.1% Triton X-100 lysed) - Abs405nm (non treated)]. 
 
In vitro DNA interaction 
Genomic DNA (gDNA ) from Candida albicans was purified with a QIAamp® DNA Mini Kit (Qiagen, 
Hilden, Germany). The quality and the concentration of DNA were estimated by measuring UV 
absorbance with NanoVue Plus spectrophotometer (GE Healthcare, Freiburg, Germany). The ability 
of test compounds to bind gDNA from C. albicans was examined by agarose gel electrophoresis. For 
the gel electrophoresis experiments, gDNA (500 ng) was treated with the complexes (25 μg/mL) in 
phosphate buffer (pH 7.4), and the contents were incubated for 12 h at 37 °C, then subjected to gel 
electrophoresis on 0.8% (w/v) agarose gel containing 0.1 μg/mL of ethidium bromide in TAE buffer 
(40 mM Tris acetate/1 mM EDTA, pH 7.4) buffer at 60 V for 2 h.  
 
Zebrafish embryotoxicity assay 
The assessment of toxicity (lethality and teratogenicity) of selected thiepines on zebrafish embryos 
have been performed following general rules of the OECD Guidelines for the Testing of Chemicals 
(OECD, 2013). All experiments involving zebrafish were performed in compliance with the European 
directive 86/609/EEC and the ethical guidelines of Guide for Care and Use of Laboratory Animals of 
Institute for Molecular Genetics and Genetic Engineering, University of Belgrade. 
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Adult zebrafish (Danio rerio, wild type) were maintained in the fish medium (2 mM CaCl2, 0.5 mM 
MgSO4, 0.7 mM NaHCO3, 0.07 mM KCl) at 27 ± 1°C and 14 h light/10 h dark cycle, and regularly fed 
twice daily with commercially dry flake food supplemented with Artemia nauplii (TetraMinTM flakes; 
Tetra Melle, Germany). Eggs at 6 hours post fertilization (hpf) were treated with six different 
concentrations of selected thiepines (1, 5, 10, 25, 50 and 75 μg/mL) and 0.15% (v/v) DMSO as 
negative control. Embryos were then individually transferred into 24-well plates containing 1000 μL 
test solution, 10 embryo per well, and incubated at 28°C. Experiments were repeated two times, 
using 30 embryos per concentration.  
 
Apical endopoints (Table S1) for toxicity evaluation were recorded at 24, 48, 72, and 96 hpf using an 
inverted microscope (CKX41; Olympus, Tokyo, Japan. At 96 hpf, the embryos were anesthetized by 
addition of 0.1% (w/v) tricaine solution (Sigma-Aldrich, St. Louis, MO), photographed and killed by 
freezing at −20°C for ≥ 24 h. 
 
Results and Discussion 
Chemistry 
Thiepine derivatives 3 and 4 were used as the multifunctional building blocks for the synthesis of the 
differently substituted benzothiepino[3,2-c]pyridines. We performed the simple alkene bromination 
reaction on thiepine derivative 3. The base-promoted HBr-elimination of the vicinal dibromide 6 
gave vinyl bromides 7 and 8 with good regioselectivity (Scheme 2) (16). DBU/DMF (17), afforded the 
same product distribution of the elimination reaction.  
 
 
Scheme 2. Reagents and conditions: (i) Br2, CCl4, r.t.; (ii) KOt-Bu, t-BuOH, 85 °C. 
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Since the isomeric products 7 and 8 could be easily separated, we proceeded with further 
transformations. Vinyl bromides 7 and 8 and the previously synthesized thiepine 4 were successfully 
coupled with a series of arylboronic acids under Suzuki cross-coupling reaction conditions (18), 
affording compounds 9-18 in moderate to excellent yields (Scheme 3). The compound 7 was coupled 
with thiophenols via the palladium catalyzed reaction, using the 1,1′-
bis(diphenylphosphino)ferrocene (dppf) as a ligand, as shown in the Scheme 3. All the products 
containing the cyano group were subjected to the reaction with ethylenediamine in the presence of 
sulphur to give 2-substituted 2-imidazolines 21-23 (19). 
 
S
N
R3
S
N
R5 R2R4
ii
9: R4 = H, R5 = Ph, 50%
10: R4 = H, R5 = 4-MeO-Ph, 92%
11: R4 = H, R5 = 4-F-Ph, 60%
12: R4 = H, R5 = 4-CN-Ph, 58%
13: R4 = H, R5 = 4-Pyr, 53%
14: R4 = Ph, R5 = H, 64%
15: R4 = 4-MeO-Ph, R5 = H, 93%
4: R1 = Cl, R2 = H, R3 = H
7: R1 = H, R2 = H, R3 = Br
8: R1 = H, R2 = Br, R3 = H
R1i
S
N
R6
16: R6 = Ph, 50%
17: R6 = 4-MeO-Ph, 62%
18: R6 = 4-CN-Ph, 36%
19: Ar = Ph, 77%
20: Ar = 4-CN-Ph, 67%
iii
23: R6 =
N
H
N
22: Ar =
N
H
N21: R4 = H, R5 =
N
H
N
S
N
SAr
iv
iv
iv
88%
85%
80%
 
Scheme 3. Reagents and conditions: (i) ArB(OH)2, Pd(OAc)2, PPh3, DME, Na2CO3 aq, EtOH, 90 °C; (ii) 
ArB(OH)2, Pd(OAc)2, SPhos, K3PO4, PhMe, 100 °C; (iii) ArSH, Pd2dba3, dppf, NaOt-Bu, PhMe, 90 °C; (iv) 
H2NCH2CH2NH2, S, 110 °C, μW. 
 
Antimicrobial activity 
All synthesized thiepines were assessed for antimicrobial activity against two fungi (Candida albicans 
and clinical strain C. parapsilosis) and two bacterial strains (Pseudomonas aeruginosa and 
Staphylococcus aureus) by determination of minimum inhibitory concentration (MIC) using the broth 
dilution method in comparison with clinically used antifungals voriconazole and nystatin and 
antibacterial kanamycin (14).From the MIC concentrations, it was obvious that the most synthesized 
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of thiepines did not show significant antibacterial activity (MICs≥500 µg/mL), suggesting selectivity 
towards fungi (Table 1). MIC values against fungal strains were between 15.62 and 250 µg/mL, with 
the most potent derivative being 16 (Table 1). Thiepines 4 and 5, with chlorine and methoxy-
substituent on the phenyl ring, showed better antifungal activity than corresponding unsubstituted 
analog 3. Interestingly, in our previous study 4 did not show significant antifungal activity in the disc 
diffusion assay (4), suggesting possible interaction with cellulose discs. Antifungal activity of 4 and 5 
was not significantly dependent on the electronic effect of substituent.  In the case of compound 16 
introduction of the phenyl ring on thiepine core was beneficial for activity in comparison to 3. 
Nevertheless, in the case of compounds 17 and 18 additional substituent on phenyl ring reduced the 
antifungal activity. 
Compounds 9 and 10 showed a four-fold greater potency (MIC = 31.25 µg/mL) than unsubstituted 
thiepine 3 in inhibiting the growth of the C. albicans.  On the other hand, thiepines 11, 12, 19 had 
the same activity, while pyridine analog 13 was less potent than 3.  Among the isomeric thiepines 16 
was 2 times more active than 9, and 16 times more potent than 14 (Table 1). Similar difference in 
activity was observed for 10 and 15 analogs. Based on the obtained results it is obvious that position 
of the phenyl ring was essential for the antifungal activity. 
It is known that 2-substituted 2-imidazolines are potent antimicrobials (20). In the case of thiepine 
21 a lower antifungal activity was observed in comparison to 9. Nevertheless, 23 showed to be 
potent with similar activity to 16 against C. albicans, and 8-fold greater potency than 16 in inhibiting 
the growth of C. parapsilosis. This is important due to the fact that C. parapsilosis spp. are often 
inherently resistant and are prone to acquired resistance to antifungal drugs (in this case C27 is 
voriconazole resistant clinical isolate). MIC concentrations determined in this study were quite 
comparable to MIC concentrations obtained for recently reported 1,5-benzodiazepine (21) and 
eugenol (22) derivatives against selection of fungal strains. 
The effect of thiepines with antifungal MIC values ≤ 31.2 µg/mL on the C. albicans hyphal growth has 
also been evaluated on Spider medium as previously described (23) (Figure 2). The hyphal formation 
is essential for Candida spp. penetration into human cells during the initial phases of infection, as 
well as for biofilm formation.  Therefore, compounds that could inhibit hyphal formation are sought 
after. The tested compounds were compared with VOR as a standard and showed variable results. 
Thiepines 4 and 23 successfully prevented hyphal formation while compounds 9 and 10 showed the 
opposite effect, significantly stimulating hyphal formation, which we considered as a negative trait 
that eliminated these two derivatives from further assessments (Figure 2). 
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Figure 2. Effect of subinhibitory amounts (MIC70; 70 % of MIC determined against C. albicans for 
each compound was present in the Spider medium) of selected thiepines on C. albicans hyphal 
formation. 
We next carried out the hemolysis assay in order to explore the potential interactions of selected 
thiepines with the cell membrane (Figure 3A) and observed the activity of 4, 16 and 23 on C. albicans 
cells over 5 h using fluorescent microscopy (Figure 3B). The sheep red blood cells and thiepines were 
co-incubated in buffer at physiologic pH whereby erythrocyte membrane served as a model for the 
lipid bilayer. The percent of red blood cell disruption was quantified relative to positive control 
samples lysed with a Triton X detergent as described previously (24).  Low hemolysis of up to 10% at 
physiologic pH (7.4) was observed using 4, 16 and VOR at determined C. albicans MIC concentrations 
(Figure 3A). This implied that membrane was not the primary target of these molecules, which has 
been known for VOR. On the contrary, 23 efficiently caused between 30 and 40% hemolysis 
comparable to that of NYS that was previously shown for antifungal polyenes including nystatin due 
to the ability to cause large nonselective perforations in the cell membranes (25). This was mirrored 
in the microscopic study, which showed that NYS and 23 efficiently caused reduction in total cell 
numbers within first 5 h of treatment, while 4, 16 and VOR caused reduction in metabolic activity in 
comparison to untreated sample, seen as lesser amount of cells containing orange-red or yellow-
orange fluorescent intravacuolar structures (Figure 3B), and needed prolonged incubation time of up 
to 24 h, to cause complete fungal culture death (data not shown). Thus possible activity on the 
fungal membrane was concluded for thiepine 23 and ruled out for 4 and 16. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
Figure 3. Activity of thiepines 4, 16, 23, nystatin (NYS) and voriconazole (VOR) on A) washed sheep 
red blood cells in hemolysis assay using MIC concentrations of all tested compounds,  and B) C. 
albicans culture monitored by fluorescent microscopy after 5 h treatment (white bar represents 10 
µm; × 40 magnification). 
 
Further, we studied in vitro interaction of selected thiepines with C. albicans genomic DNA using gel 
electrophoresis assay (22) after prolonged incubation (12 h) of compounds (25 µg/mL) with purified 
DNA (Figure 4). Under tested conditions, thiepines did not cause DNA degradation, while significant 
interacalation with DNA based on lower UV-luminescence upon exposure to ethidium bromide was 
exhibited by 4 and 23 by 30 and 60% of the DMSO treated control, respectively (Figure 4) and hence 
it was reasonable to attribute some of the activity of these compounds to interaction with this 
biomolecule. The DNA binding property of 2-imidazoline derivatives is well described in the 
literature (26), and therefore our result for compound 23 is well correlated with the literature data. 
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Figure 4. In vitro interaction of the thiepines 4, 16, 23 and voriconazole (VOR) with genomic DNA 
(gDNA) from C. albicans (results are considered significant when compared to the DMSO control: 
***p<0.001 and **p<0.01; M is molecular weight standard). 
 
In vivo embryotoxicity assessment 
Zebrafish has emerged as a versatile platform for drug discovery, as findings from experiments 
including this organism translate more accurately into the context of human body in terms of toxicity 
and bioavailability simplifying the path to clinical trials and reducing the failure of potential 
therapeutics at later stages of testing (27). Therefore, the toxicity of the most promising thiepines 
(the lethality and teratogenicity; see Supporting Information Table S1) was evaluated. Obtained 
results revealed different toxicity-profiles of tested compounds, and according to LC50 and EC50 
values they were ranked by toxicity: 23>16> 4 (Figure 5; Table S2). Embryos exposed to 4 were 
developed without signs of toxicity at concentrations up to 50 µg/mL, while at 75 µg/mL only 13% of 
embryos were affected (Figure 5). All alive embryos upon exposure to 75 µg/ml of 16 were reduced 
in growth and had serious skeletal deformities (lordosis, deformed tail, small head, malformed eyes) 
accompanied with pericardial edema, while at lower concentrations 16 exhibited very weak toxicity 
(Figure 5). Completely lethal outcome before hatching was caused by 23 at 75 µg/mL, while lower 
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concentrations of 23 caused pericardial edema and skeletal abnormalities of embryos (scoliosis, 
deformed eyes, head and tail tip). At 50 µg/mL, 23 prevented hatching of 58% embryos (Figure 5; 
Table S2). All three thiepines exhibited desirable higher LC50 value on zebrafish embryos in 
comparison to MIC against C. albicans (Figure 5; Table 1). From this test, only 23 showed undesirable 
high teratogenicity with EC50 value higher than MIC against C. albicans (Figure 5; Table 1). In our 
recent study, we have shown high teratogenic effect of clinically used VOR.22 Thus, these findings 
imply that selected thiepines could be further developed for the antifungal treatment. 
 
 
Figure 5. In-vivo toxicity of thiepines 4, 16 and 23 on zebrafish embryos. LC50 and EC50 values (µg/mL) 
were derived from the concentration-response curves for thiepines in zebrafish toxicity assay at 96 
hpf. Teratogenic effect on embryos: dashed arrow – pericardial edema, arrow – lordosis, black 
arrowhead – malformed tail, empty arrowhead – kyphosis, asterisk – malformed eyes, bracket – 
malformed head. 
 
Conclusion 
A series of thiepines was designed, synthesized and their antimicrobial properties were evaluated. 
Analyzed thiepines showed higher antifungal activity than antibacterial activity. From biological 
activity screening it was evident that the position of the phenyl ring was essential for the antifungal 
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activity. On the other hand, the electronic effects of substituents did not significantly influence 
activity. The most potent thiepine, 16, had an MIC of 15.6 μg/mL and showed no embryo toxicity at 
75 μg/mL, providing evidence that this chemotype provides a good platform for further 
optimization. 
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Figure Legends and Tables 
Figure 1. Structure of zotepine. 
Scheme 1. Reagents and conditions: (i) Pd(OAc)2, dppf, KSAc, NaOt-Bu, PhMe, 175 °C, μW. 
Scheme 2. Reagents and conditions: (i) Br2, CCl4, r.t.; (ii) KOt-Bu, t-BuOH, 85 °C. 
Scheme 3. Reagents and conditions: (i) ArB(OH)2, Pd(OAc)2, PPh3, DME, Na2CO3 aq, EtOH, 90 °C; (ii) 
ArB(OH)2, Pd(OAc)2, SPhos, K3PO4, PhMe, 100 °C; (iii) ArSH, Pd2dba3, dppf, NaOt-Bu, PhMe, 90 °C; (iv) 
H2NCH2CH2NH2, S, 110 °C, μW. 
Figure 2. Effect of subinhibitory amounts (MIC70) of selected thiepines on C. albicans hyphal 
formation. 
Figure 3. Activity of thiepines 4, 16, 23, nystatin (NYS) and voriconazole (VOR) on A) washed sheep 
red blood cells in hemolysis assay using MIC concentrations of all tested compounds,  and B) C. 
albicans culture monitored by fluorescent microscopy after 5 h treatment (white bar represents 10 
µm; × 40 magnification). 
Figure 4. In vitro interaction of the thiepines 4, 16, 23 and voriconazole (VOR) with genomic DNA 
(gDNA) from C. albicans (results are considered significant when compared to the DMSO control: 
***p<0.001 and **p<0.01; M is molecular weight standard). 
Figure 5. In-vivo toxicity of thiepines 4, 16 and 23 on zebrafish embryos. LC50 and EC50 values 
(µg/mL) were derived from the concentration-response curves for thiepines in zebrafish 
toxicity assay at 96 hpf. Teratogenic effect on embryos: dashed arrow – pericardial edema, 
arrow – lordosis, black arrowhead – malformed tail, empty arrowhead – kyphosis, asterisk – 
malformed eyes, bracket – malformed head. 
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Table 1. In-vitro antimicrobial activity of thiepines in comparison to clinically used drugs given as 
minimal inhibitory concentrations (MICs, µg/mL) 
Compound 
Antifungal activity Antibacterial activity 
C. albicans 
ATCC10231 
C. parapsilosis 
C27 
P. aeruginosa S. aureus  
2 250 250 500 >500 
3 125 >500 250 200 
4 31.25 250 500 >500 
5 62.5 125 250 250 
7 125 >500 >500 200 
9 31.2 250 >500 >500 
10 31.2 62.5 >500 >500 
11 125 500 >500 >500 
12 125 62.5 500 >500 
13 500 250 500 >500 
14 250 >500 250 125 
15 250 250 500 >500 
16 15.6 250 >500 >500 
17 125 >500 125 250 
18 250 250 500 250 
19 125 >500 >500 >500 
20 125 500 500 500 
21 250 250 250 100 
22 125 62.5 250 500 
23 31.2 31.2 125 500 
VORa 0.5 R / / 
NYS 2 2 / / 
KAN / / 50 10 
 
a Control drug: voriconazole (VOR); nystatin (NYS); kanamycin (KAN) 
 
